M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

NEWSWelcome to the April edition of the MASCC Society NewsMessage from Editors Anna Ugalde and Anna Boltong

In this issue of our newsletter we present David Warr, MASCC president-elect. In our interview with David he shared his research interests, his passion for education and his thoughts on the future of MASCC’s role in supportive care education. We also bring you details of an upcoming conference relevant to MASCC members, the International Society of Nurses in Cancer Care Conference. This important event will be held in September 2014 in Panama City, Panama. We also bring you profiles of two new members and also a list of some recent publications by MASCC members. We look forward to hearing from you regarding stories, publications, innovative research, awards or other news to include in future editions. We hope you enjoy this edition of the Society News.

From your editors, Anna & Anna

April 2014

Congratulations to Dr. David Warr who will serve as the MASCC president from June 2014 – June 2016. David lives in Toronto, Canada, and works at the Princess Margaret Cancer Centre. In our interview with David we discussed research interests, supportive care education and his personal reflections.

What publications have you enjoyed recently?My favourite recent manuscript was published in our journal, Supportive Care in Cancer. Drs. Hesketh, Carides and James Street reported on the time course of aprepitant in preventing cisplatin and AC (doxorubicin, cyclosphosphamide) induced emesis. Although the impression had been that NK1 receptor antagonists had their benefits primarily beyond 24 hours, the analysis showed substantial benefits that began quite soon after chemotherapy had been given. The pattern of emesis following ondansetron and dexamethasone also appeared to be the opposite of what was classically taught - it was unimodal for cisplatin and bimodal for AC. These results were surprising and challenged conventional wisdom, which is something that I always enjoy.

Is there a component of supportive care you are particularly passionate about?Education is a passion for me. I love to listen to a speaker who is enthusiastic, teaches me something new and delivers it in a clear fashion with plenty of time for discussion. The annual MASCC/ISOO meeting is the premier event for supportive care in cancer education. Since about 70% of those who attend the annual meeting are not MASCC members, each meeting is a new opportunity to reach out to a large community of non-MASCC professionals who are delivering supportive care.

What does this mean for how you could enhance MASCC’s role in supportive care education?Although the annual meeting is an effective platform for presenting research and contains interesting didactic sessions, it lacks much in the way of case-based sessions that show the application of evidence based supportive care to daily practice. I introduced a case based-audience participation session in Vancouver which attracted large crowds at a very early hour in the morning. There was a lot of positive feedback from the audience. I'd like to see that type of session again at future conferences because I want participants to go home thinking that they can introduce a

Meet the Incoming President of MASCC, Dr. David Warr

M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

Incoming President of MASCC, (continued)

change in their practice or be assured that what they are doing is state of the art. We also need to think about how to expand our education in supportive care to our work places. That is a major challenge, but we have a lot of highly talented people within MASCC who are passionate about supportive care.

Can you tell us about a time you turned a challenge into an opportunity?Recently we were without power in Toronto for 4 days including Christmas day due to a major ice storm. Since the temperature was far below freezing, many of our neighbours moved out but we managed to keep warm safely with an innovative use of a natural gas stove top. On Christmas morning I was outside in pitch black at 630 a.m. barbecuing our massive 25 lb turkey. Although I had never barbecued a turkey the results were excellent and we had a wonderful meal with family. I was pleasantly surprised that we could easily "survive" several days without the internet or television and that everyone was content reading by candlelight!

The manuscript David refers to is: Hesketh PJ, Warr DG, Street JC, Carides AD. Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC). Support Care Cancer. 2011 Sep;19(9):1297-302.

18th International Society of Nurses in Cancer Care Conference • September 7-11, 2014 • Panama City, Panama

The International Society of Nurses in Cancer Care (ISNCC) will host the 18th International Conference on Cancer Nursing (ICCN) at the Hilton Panama, Panama City, Panama on September 7 - 11, 2014. The theme for this year's conference is Strengthening Leadership, Unity and Compassion in Cancer Care. Held biennially, the ICCN is the premier educational and networking event for oncology nurses. In 2012, the 17th International Conference on Cancer Nursing was held in Prague, Czech Republic, and featured

over 150 oral presentations, 300 poster presentations and 605 attendees from 53 countries. In 2014, ISNCC is looking forward to welcoming MASCC members and cancer nursing professionals from all of the world to Panama. Early registration will close on the 15th May 2014, and you can register and view the list of speakers from the ICCN website at: http://www.isncc.org/

Meet a new MASCC Member - Josaih HalmMy name is Josiah K. Halm and I am Assistant Professor of Medicine, Department of General Internal Medicine, Section Chief of Hospital Medicine and Quality Officer, University of Texas MD Anderson Cancer Center, Houston, Texas. I provide inpatient care to the hospitalized cancer patient. I manage a lot of symptoms related to both the burden of malignancies and also those patients experience from treatment side effects. I have joined MASCC as an avenue to meet other colleagues who manage cancer patients to network and collaborate on research on an international stage.

M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

Meet a new MASCC Member - Takashi Yurikusa I am chief of the dental department at the Shizuoka Cancer Center Hospital located at the foot of Mt. Fuji in Japan. My clinical practice includes outpatient and inpatient dental care and oral management.

I'm involved in supportive care to prevent or reduce oral complications related to cancer and its treatment. I'm very interested in improving my knowledge of supportive care. I was fortunate to have a dedicated mentor, Dr. Yojiro Ota, who was the previous chief of the dental department and a leader in the field of dentistry in Japan. His main work was in the oral care of cancer patients with a focus on patients' quality of life. Dr. Ota was one of the first members of MASCC/ISOO from Japan. His influence has led to an increased presence and contribution of others from Japan. Unfortunately, he passed away suddenly last year, and in his honour, I hope to continue the important work he has started, and contribute as a member of MASCC/ISOO.

Publications from MASCC members 1: Bush SH, Kanji S, Pereira JL, Davis DH, Currow DC, Meagher D, Rabheru K, Wright D, Bruera E, Agar M, Hartwick M, Gagnon PR, Gagnon B, Breitbart W, Regnier L, Lawlor PG. Treating an Established Episode of Delirium in Palliative Care: Expert Opinion and Review of the Current Evidence Base With Recommendations for Future Development. J Pain Symptom Manage. 2014 Jan 28.

2: Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Rev Respir Med. 2014 Jan 22.

3: Young JM, Stacey I, Dobbins TA, Dunlop S, Dessaix AL, Currow DC. Association between tobacco plain packaging and Quitline calls: a population-based, interrupted time-series analysis. Med J Aust. 2014 Jan 20;200(1):29-32.

4: Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Martin JR, Keeney GL, Jatoi A, Gostout BS, Podratz KC. Efficacy of contemporary chemotherapy in stage IIIC endometrial cancer: A histologic dichotomy. Gynecol Oncol. 2014 Jan

5: Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Performance of a Nomogram Predicting Disease-Specific Survival After an R0 Resection for Gastric Cancer in Patients Receiving Postoperative Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2014 Jan 7.

6: Grindlay DJ, Dean RS, Christopher MM, Brennan ML. A survey of the awareness, knowledge, policies and views of veterinary journal Editors-in-Chief on reporting guidelines for publication of research. BMC Vet Res. 2014 Jan 10;10(1):10.

7: Leal AD, Kadakia KC, Looker S, Hilger C, Sorgatz K, Anderson K, Jacobson A,Grendahl D, Seisler D, Hobday T, Loprinzi CL. Fosaprepitant-induced phlebitis: a focus on patients receiving oxorubicin/cyclophosphamide therapy. Support Care Cancer. 2014 Jan 9.

8: Takahashi H, Epstein JI, Wakui S, Yamamoto T, Furusato B, Zhang M. Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan. Prostate. 2014 Feb;74(3):321-5.

9: Kolnick L, Deng J, Epstein JB, Migliorati CA, Rezk J, Dietrich MS, Murphy BA. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Oral Oncol. 2014 Feb;50(2):135-40.

10: Ananthanarayanan V, Pan Y, Tretiakova M, Amin MB, Cheng L, Epstein JI, Grignon DJ, Hansel DE, Jimenez RE, McKenney JK, Montironi R, Oliva E, Osunkoya AO, Rao P, Reuter VE, Ro JY, Shen SS, Srigley JR, Tsuzuki T, Yao JL, Antic T, Haber M, Taxy JB, Paner GP. Influence of Histologic Criteria and Confounding Factors in Staging Equivocal Cases for Microscopic Perivesical Tissue Invasion (pT3a): An Interobserver Study Among Genitourinary Pathologists. Am J Surg Pathol. 2014 Feb;38(2):167-75.

11: Currow DC, Abernethy AP. Lessons from the Liverpool Care Pathway--evidence is key. Lancet. 2014 Jan 18;383(9913):192-3. doi: 10.1016/S0140-6736(13)62039-5. Epub 2013 Oct 16.

12: Smith SK, Rowe K, Abernethy AP. Use of an electronic patient-reported outcome measurement system to improve distress management in oncology. Palliat Support Care. 2014 Feb;12(1):69-73.

M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

Have any news items to share?

Please send contributions for the MASCC News to MASCCnews@mascc.org or the co-editors:

Anna Ugalde anna.ugalde@svhm.org.au and Anna Boltong anna.boltong@cancervic.org.au

For more information please contact: Åge Schultz, MASCC Executive Director: aschultz@mascc.org

Join MASCC before June 1st for up to $200 in registration savings and bene!ts!

Publications from MASCC members (continued)

13: Blufpand HN, Hes N, Bökenkamp A, van de Wetering MD, Kaspers GJ. Diversity in renal function monitoring and dose modifications during treatment for childhood cancer: A call for standardization. Pediatr Blood Cancer. 2014 Feb;61(2):337-44.

14: Cantarero-Villanueva I, Fernández-Lao C, Díaz-Rodríguez L, Cuesta-Vargas AI, Fernández-de-Las-Peñas C, Piper BF, Arroyo-Morales M. The Piper Fatigue Scale-Revised: translation and psychometric evaluation in Spanish-speaking breast cancer survivors. Qual Life Res. 2014 Feb;23(1):271-6.

15: Nicolatou-Galitis O, Razis E, Galiti D, Vardas E, Tzerbos F, Labropoulos S. Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib-A case report with clinical implications. Forum Clin Oncol 2013;4:29-33.